Rights and permissions
About this article
Cite this article
GSK and Health Canada warn about risk of MI with fosamprenavir. React. Wkly. 1263, 2 (2009). https://doi.org/10.2165/00128415-200912630-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200912630-00004